Publication Cover
Neurocase
Behavior, Cognition and Neuroscience
Volume 25, 2019 - Issue 3-4
182
Views
4
CrossRef citations to date
0
Altmetric
Articles

Successful treatment of psychosis in a patient with Kufor-Rakeb syndrome with low dose aripiprazole: a case report

, , , &
Pages 133-137 | Received 11 Jul 2018, Accepted 20 May 2019, Published online: 24 Jun 2019

References

  • Behrens, M. I., Brüggemann, N., Chana, P., Venegas, P., Kägi, M., Parrao, T., … Ramirez, A. (2010). Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations. Movement Disorders, 25, 1929–1937. doi:10.1002/mds.22996
  • Carbon, M., Kapoor, S., Sheridan, E., Al-Jadiri, A., Azzo, S., Sarkaria, T., … Correll, C. U. (2015). Neuromotor adverse effects in 342 youth during 12 weeks of naturalistic treatment with 5 second-generation antipsychotics. Journal of the American Academy of Child and Adolescent Psychiatry, 54, 718–727.e3. doi:10.1016/j.jaac.2015.06.015
  • Di Fonzo, A., Chien, H. F., Socal, M., Giraudo, S., Tassorelli, C., Iliceto, G., … Bonifati, V. (2007). ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology, 68, 1557–1562. doi:10.1212/01.wnl.0000260963.08711.08
  • Farias, F. H. G., Zeng, R., Johnson, G. S., Wininger, F. A., Taylor, J. F., Schnabel, R. D., … Katz, M. L. (2011). A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers. Neurobiology of Disease, 42, 468–474. doi:10.1016/j.nbd.2011.02.009
  • Friedman, J. H. (2010). Parkinson’s disease psychosis 2010: A review article. Parkinsonism & Related Disorders, 16, 553–560. doi:10.1016/j.parkreldis.2010.05.004
  • Friedman, J. H. (2010). Parkinsonism & Related Disorders, 16, 553–560. doi: 10.1016/j.parkreldis.2010.05.004
  • Friedman, J. H., Berman, R. M., Goetz, C. G., Factor, S. A., Ondo, W. G., Wojcieszek, J., … Marcus, R. N. (2006). Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 21, 2078–2081. doi:10.1002/mds.21091
  • Guy, W. (1976) ECDEU assessment manual for psychopharmacology (Rev. 1976.). Rockville, MD: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs.
  • Guy, W. (1976). ECDEU assessment manual for psychopharmacology (Rev. 1976.). Rockville, MD: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs.
  • Marcus, R. N., Owen, R., Kamen, L., Manos, G., McQuade, R. D., Carson, W. H., & Aman, M. G. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1110–1119. doi:10.1097/CHI.0b013e3181b76658
  • Meco, G., Stirpe, P., Edito, F., Purcaro, C., Valente, M., Bernardi, S., & Vanacore, N. (2009). Aripiprazole in L-dopa-induced dyskinesias: A one-year open-label pilot study. Journal of Neural Transmission (Vienna, Austria: 1996), 116, 881–884. doi:10.1007/s00702-009-0231-z
  • Najim Al-Din, A. S., Wriekat, A., Mubaidin, A., Dasouki, M., & Hiari, M. (1994). Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurologica Scandinavica, 89, 347–352. doi:10.1111/j.1600-0404.1994.tb02645.x
  • Okazaki, M., Adachi, N., Akanuma, N., Hara, K., Ito, M., Kato, M., & Onuma, T. (2014). Do antipsychotic drugs increase seizure frequency in epilepsy patients? European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology, 24, 1738–1744. doi:10.1016/j.euroneuro.2014.09.012
  • Schneider, S. A., Paisan-Ruiz, C., Quinn, N. P., Lees, A. J., Houlden, H., Hardy, J., & Bhatia, K. P. (2010). ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Movement Disorders: Official Journal of the Movement Disorder Society, 25, 979–984. doi:10.1002/mds.22947
  • Williams, D. R., Hadeed, A., Al-Din, A. S. N., Wreikat, A.-L., & Lees, A. J. (2005). Kufor Rakeb disease: Autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Movement Disorders: Official Journal of the Movement Disorder Society, 20, 1264–1271. doi:10.1002/mds.20511

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.